Peptides attract a lot of online enthusiasm, and claims often run well ahead of the evidence. Here is how scientists judge whether a finding is solid.
Not all evidence is equal
Different kinds of study answer different questions, and they carry very different weight:
| Study type | What it can show | Main limitation |
|---|---|---|
| In vitro (cells, tissues) | A possible mechanism | Cells in a dish aren't a whole organism |
| Animal studies | Effects in a living system | Often don't carry over to humans |
| Case reports and anecdotes | Something worth investigating | No control group; prone to bias and placebo effects |
| Observational studies | Associations in real populations | Correlation isn't causation |
| Randomised controlled trials | Whether an intervention causes an effect | Expensive, and sometimes small or short |
| Systematic reviews and meta-analyses | The combined weight of many trials | Only as good as the studies included |
Many peptides discussed online have been studied only in cells or rodents. A striking result in a rat model is a reason to do more research, not evidence that something works or is safe in people.
Questions to ask about any study
- Who or what was studied? Cells, mice or people? How many?
- Was there a control group? Was it randomised and blinded?
- What was measured? A real outcome, or a surrogate marker such as a lab value?
- How big was the effect? Statistically significant isn't the same as meaningful.
- Has it been replicated by an independent group?
- Is it peer-reviewed? Preprints are useful but haven't been checked yet.
- Who funded it? Conflicts of interest don't invalidate work, but they're worth knowing about.
Red flags
- Claims backed only by testimonials or before-and-after photos
- "Studies show…" with no citation, or citations that don't say what's claimed
- Animal results described as if they apply to humans
- Words like "miracle", "breakthrough" or "no side effects"
- Sources that profit from the claim being believed
Where to find reliable information
- PubMed (pubmed.ncbi.nlm.nih.gov): the main index of biomedical literature
- ClinicalTrials.gov and the ISRCTN registry: registered human trials and their results
- Cochrane reviews: rigorous systematic reviews
- Regulators: the MHRA, EMA and FDA publish assessment reports for approved medicines
Rule of thumb: the more surprising the claim, the stronger the evidence it needs, and that means randomised human trials, not mechanisms and mouse models.
Related articles
- How clinical trials are designed
- What "research use only" actually means
- How laboratories validate analytical methods
Sources and further reading
- Ioannidis JPA. Why most published research findings are false. PLoS Med 2005;2:e124. doi:10.1371/journal.pmed.0020124 · PMID: 16060722
- Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332. doi:10.1136/bmj.c332 · PMID: 20332509
- PubMed. pubmed.ncbi.nlm.nih.gov
- ClinicalTrials.gov. clinicaltrials.gov
- ISRCTN registry. www.isrctn.com
- Cochrane Library. www.cochranelibrary.com
Back to: All articles →